Abstract
Background In 2015, the World Health Organization introduced the concept of intrinsic capacity (IC) to define the individual-level characteristics that enable an older person to be and do the things they value. This study developed an IC score for UK Biobank (UKB) study participants and validated its use as a tool for health outcome prediction, understanding healthy aging trajectories, and genetic research.
Methods Our analysis included data from 45,208 UKB participants who had a complete record of the ten variables included in the analysis. Factor adequacy was tested using Kaiser–Meyer– Olkin (KMO), Barthelt’s, and the determinant of matrix tests, and the number of factors was determined by the parallel analysis method. Exploratory and confirmatory factor analyses were employed to determine the structure and dimensionality of indicators. Finally, the IC score was generated, and its construct and predictive validities as well as reliability were assessed.
Results The factor analysis identified a multidimensional construct comprising, one general factor (IC) and five specific factors (locomotor, vitality, cognitive, psychological, and sensory). The bifactor structure showed a better fit (comparative fit index = 0.995, Tucker Lewis index = 0.976, root mean square error of approximation = 0.025, root mean square residual = 0.009) than the conventional five-factor structure. The IC score, generated using the bifactor confirmatory factor analysis has good construct validity, as demonstrated by an inverse association with age (lower IC in older age; beta = -0.035 (95%CI: -0.036, -0.034)), frailty (lower IC score in prefrail, beta = -0.104 (95%CI: (-0.114, -0.094) and frail, beta = -0.227 (95%CI: -0.267, -0.186) than the robust), and Charlson’s comorbidity index (CCI) for incident cases (a lower IC score associated with increased CCI, beta, = -0.019 (95%CI: -0.022, -0.015). The IC score also predicted incident CCI (a one-unit increase in baseline IC score led to lower CCI, beta = 0.147 (95%CI: -0.173, - 0.121)).
Conclusion The bifactor structure showed a better fit in all goodness of fit tests. The IC construct has strong structural, construct, and predictive validities and it is a promising tool for monitoring aging trajectories.
Highlights
Large biobank studies should be leveraged with intrinsic capacity scores developed.
Factor analysis confirmed IC as one general factor and five specific factors.
Better goodness of fit observed with the bifactor model versus conventional structure.
The bifactor model IC score has a good construct and predictive validity.
The IC score can be used as a single reliable measure of IC.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MB Beyene received postgraduate scholarship support from the University of Adelaide (The University Adelaide Research Scholarship) and AT Amare is currently supported by National Health and Medical Research Council (NHMRC) Emerging Leadership (EL1) Investigator Grant (APP2008000). Access to the UK Biobank data was partially supported by funding from the Hospital Research Foundation to Professor Visvanathan.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The UK Biobank has full ethical approval from the NHS National Research Ethics Service and informed consent was obtained before data collection from each participant. This study was conducted using the UK biobank resource under application number 70215.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
This study was conducted using the UK biobank dataset under application number 70215.
